Trials supporting selective COX-2 inhibitor safety seriously flawed Comment 23 January 2013 Pages: 2 - 2
'Topamax' label update: risk of oligohidrosis and hyperthermia Correspondence 23 January 2013 Pages: 3 - 3
Explicit liver function monitoring directions added to 'Arava' label News item 23 January 2013 Pages: 3 - 3
Atypical antipsychotics: adverse effect profile linked to treatment costs Clinical study 23 January 2013 Pages: 4 - 4
Azathioprine associated with increased risk of pancreatitis Incidence study 23 January 2013 Pages: 4 - 4
Fluoroquinolones: higher rate of AEs in paediatric patients Clinical study 23 January 2013 Pages: 5 - 5
Linezolid: no significant risk of haematological disorders Clinical study 23 January 2013 Pages: 5 - 5
Liposomal amphotericin B: high rate of infusion-related reactions Incidence study 23 January 2013 Pages: 5 - 5